Literature DB >> 31292111

Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.

Wei Jian Tan1, Mona Meng Wang2, Paola Ricciardi-Castagnoli1, Tiffany Tang3, Soon Phaik Chee4,5, Tong Seng Lim1, Anita Sook Yee Chan2,4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31292111      PMCID： PMC6706808          DOI： 10.1182/blood.2019000022

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.

Authors:  Ichiro Yonese; Hiroshi Takase; Mayumi Yoshimori; Erika Onozawa; Akiho Tsuzura; Tohru Miki; Manabu Mochizuki; Osamu Miura; Ayako Arai
Journal:  Eur J Haematol       Date:  2018-11-23       Impact factor: 2.997

2.  High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.

Authors:  Irina Bonzheim; Sabrina Giese; Christoph Deuter; Daniela Süsskind; Manfred Zierhut; Maria Waizel; Peter Szurman; Birgit Federmann; Janine Schmidt; Leticia Quintanilla-Martinez; Sarah E Coupland; Karl Ulrich Bartz-Schmidt; Falko Fend
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

3.  Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization.

Authors:  Monika Avbelj; Olaf-Oliver Wolz; Ota Fekonja; Mojca Benčina; Matej Repič; Janez Mavri; Jens Krüger; Charlotta Schärfe; Magno Delmiro Garcia; Gabriela Panter; Oliver Kohlbacher; Alexander N R Weber; Roman Jerala
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

4.  Detection of MYD88 Mutations in Vitreoretinal Lymphoma and Its Implications.

Authors:  Valerie Touitou; Myrto Costopoulos; Karim Maloum
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

5.  Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.

Authors:  Laura S Hiemcke-Jiwa; Ninette H Ten Dam-van Loon; Roos J Leguit; Stefan Nierkens; Jeannette Ossewaarde-van Norel; Joke H de Boer; Floor F Roholl; Roel A de Weger; Manon M H Huibers; Jolanda D F de Groot-Mijnes; Jonas J W Kuiper
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

6.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

7.  MYD88 L265P mutation in Waldenstrom macroglobulinemia.

Authors:  Stéphanie Poulain; Christophe Roumier; Audrey Decambron; Aline Renneville; Charles Herbaux; Elisabeth Bertrand; Sabine Tricot; Agnès Daudignon; Sylvie Galiègue-Zouitina; Valerie Soenen; Olivier Theisen; Nathalie Grardel; Olivier Nibourel; Catherine Roche-Lestienne; Bruno Quesnel; Patrick Duthilleul; Claude Preudhomme; Xavier Leleu
Journal:  Blood       Date:  2013-03-26       Impact factor: 22.113

8.  Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.

Authors:  Marzia Varettoni; Luca Arcaini; Silvia Zibellini; Emanuela Boveri; Sara Rattotti; Roberta Riboni; Alessandro Corso; Ester Orlandi; Maurizio Bonfichi; Manuel Gotti; Cristiana Pascutto; Silvia Mangiacavalli; Giorgio Croci; Valeria Fiaccadori; Lucia Morello; Maria Luisa Guerrera; Marco Paulli; Mario Cazzola
Journal:  Blood       Date:  2013-01-25       Impact factor: 22.113

9.  MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.

Authors:  Elisabetta Miserocchi; Andrés J M Ferreri; Chiara Giuffrè; Maria G Cangi; Ilaria Francaviglia; Teresa Calimeri; Maurilio Ponzoni; Lorenza Pecciarini; Francesco M Bandello; Giulio M Modorati
Journal:  Retina       Date:  2019-04       Impact factor: 4.256

10.  Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis.

Authors:  Bing-Sheng Li; Xin-Ying Wang; Feng-Li Ma; Bo Jiang; Xiao-Xiao Song; An-Gao Xu
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240
View more
  7 in total

Review 1.  [Lymphoma of the eye and its adnexa : Modern pathological diagnostics and systemic treatment].

Authors:  Falko Fend; Irina Bonzheim; Vinodh Kakkassery; Ludwig M Heindl; Gerald Illerhaus
Journal:  Ophthalmologie       Date:  2022-05-23

Review 2.  New Insights Into Immunological Therapy for Retinal Disorders.

Authors:  Atsunobu Takeda; Ryoji Yanai; Yusuke Murakami; Mitsuru Arima; Koh-Hei Sonoda
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

3.  Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling.

Authors:  Mona Meng Wang; Chuanfei Chen; Myoe Naing Lynn; Carlos R Figueiredo; Wei Jian Tan; Tong Seng Lim; Sarah E Coupland; Anita Sook Yee Chan
Journal:  Front Mol Biosci       Date:  2021-01-06

Review 4.  Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.

Authors:  Wei Jian Tan; Mona Meng Wang; Paola Ricciardi-Castagnoli; Anita Sook Yee Chan; Tong Seng Lim
Journal:  Front Mol Biosci       Date:  2021-01-11

5.  Diagnosing Vitreoretinal Lymphomas-An Analysis of the Sensitivity of Existing Tools.

Authors:  Anahita Sehgal; Jose S Pulido; Arman Mashayekhi; Tatyana Milman; Gabor Gy Deák
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

6.  The molecular hallmarks of primary and secondary vitreoretinal lymphoma.

Authors:  Irina Bonzheim; Philip Sander; Julia Salmerón-Villalobos; Daniela Süsskind; Peter Szurman; Florian Gekeler; Martin S Spitzer; Julia Steinhilber; Esther Kohler; Melanie Büssgen; Jens Schittenhelm; Itziar Salaverria; Elias Campo; Sarah E Coupland; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Blood Adv       Date:  2022-03-08

7.  High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.

Authors:  Teruumi Minezaki; Yoshihiko Usui; Masaki Asakage; Masakatsu Takanashi; Hiroyuki Shimizu; Naoya Nezu; Akitomo Narimatsu; Kinya Tsubota; Kazuhiko Umazume; Naoyuki Yamakawa; Masahiko Kuroda; Hiroshi Goto
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.